What are Some Notable IP Disputes in Cancer Research?
One notable case is the dispute between Myriad Genetics and other parties over the BRCA1 and BRCA2 genes. Myriad held patents on these genes, which are linked to a higher risk of breast and ovarian cancers. The Supreme Court eventually ruled that naturally occurring genes cannot be patented, which had significant implications for genetic research and testing.
